Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41598-017-04664-y http://scihub22266oqcxt.onion/10.1038/s41598-017-04664-y C5484693!5484693!28652624     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Sci+Rep 2017 ; 7 (ä): ä Nephropedia Template TP {{tp|p=28652624|t=2017. Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance |pdf=|usr=}}{{28652624}} gab.com Text Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance JO: Sci Rep http://www.kidney.de/pget.php?&tw=1&pmid=28652624 #FOAvip The clinical importance of serum hepcidin in non-dialysis chronic kidney disease (CKD) patients is unclear. The database of a large-scale multicentre prospective study in Korea of 2238 patients enrolled from 2011?2016 was analysed. After excluding patients with missing serum hepcidin (n?=?125) and haemoglobin (n?=?23) levels, the study included 2090 non-dialysis CKD patients. Markers of inflammation and iron status were positively associated with serum hepcidin level, regardless of CKD stage. However, estimated glomerular filtration rate was inversely associated with serum hepcidin level, particularly in patients with CKD stages 3b?5 but not in those with CKD stages 1?3a. Use of erythropoiesis-stimulating agents was associated with increased serum hepcidin levels, particularly in patients with CKD stages 3b?5 but not in those with CKD stages 1?3a, and serum hepcidin levels positively correlated with the dose of erythropoiesis-stimulating agent. These findings suggest that serum hepcidin may be a uremic toxin and play an important role in erythropoietin resistance. However, future prospective studies are needed to confirm our results. Twit Text FOAVip Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance ????Sci Rep http://www.kidney.de/pget.php?&tw=1&pmid=28652624 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28652624 #FOAvip English Wikipedia <ref>{{Cite pmid|28652624}}</ref> Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance #MMPMID28652624 Lee SW; Kim JM; Lim HJ; Hwang YH; Kim SW; Chung W; Oh KH; Ahn C; Lee KB; Sung SA Sci Rep 2017[]; 7 (ä): ä PMID28652624show ga The clinical importance of serum hepcidin in non-dialysis chronic kidney disease (CKD) patients is unclear. The database of a large-scale multicentre prospective study in Korea of 2238 patients enrolled from 2011?2016 was analysed. After excluding patients with missing serum hepcidin (n?=?125) and haemoglobin (n?=?23) levels, the study included 2090 non-dialysis CKD patients. Markers of inflammation and iron status were positively associated with serum hepcidin level, regardless of CKD stage. However, estimated glomerular filtration rate was inversely associated with serum hepcidin level, particularly in patients with CKD stages 3b?5 but not in those with CKD stages 1?3a. Use of erythropoiesis-stimulating agents was associated with increased serum hepcidin levels, particularly in patients with CKD stages 3b?5 but not in those with CKD stages 1?3a, and serum hepcidin levels positively correlated with the dose of erythropoiesis-stimulating agent. These findings suggest that serum hepcidin may be a uremic toxin and play an important role in erythropoietin resistance. However, future prospective studies are needed to confirm our results. äSerum hepcidin may be a novel uremic toxin, which might be related to (epmc).pdf DeepDyve Pubget Overpricing